|
GLCCI1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.363200E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.979100E-03 |
| Normal-vs-Stage2 |
4.221600E-02 |
| Normal-vs-Stage3 |
1.055240E-01 |
| Normal-vs-Stage4 |
2.029000E-01 |
| Stage1-vs-Stage2 |
3.692800E-01 |
| Stage1-vs-Stage3 |
4.988400E-01 |
| Stage1-vs-Stage4 |
2.267600E-01 |
| Stage2-vs-Stage3 |
2.442400E-01 |
| Stage2-vs-Stage4 |
1.515970E-01 |
| Stage3-vs-Stage4 |
6.684800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.597600E-04 |
| Normal-vs-AfricanAmerican |
9.781000E-01 |
| Normal-vs-Asian |
2.846800E-01 |
| Caucasian-vs-AfricanAmerican |
4.156200E-03 |
| Caucasian-vs-Asian |
9.219600E-01 |
| AfricanAmerican-vs-Asian |
1.276410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.971100E-04 |
| Normal-vs-Female |
8.485800E-02 |
| Male-vs-Female |
6.267700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.301400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.700500E-03 |
| Normal-vs-Age(61-80Yrs) |
1.321590E-02 |
| Normal-vs-Age(81-100Yrs) |
6.066800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.610270E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.728000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.264800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.430400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.874100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.101600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.080000E-01 |
| Normal-vs-Grade 2 |
3.815500E-03 |
| Normal-vs-Grade 3 |
2.782100E-02 |
| Normal-vs-Grade 4 |
3.494400E-01 |
| Grade 1-vs-Grade 2 |
3.333800E-01 |
| Grade 1-vs-Grade 3 |
7.177000E-01 |
| Grade 1-vs-Grade 4 |
9.124400E-01 |
| Grade 2-vs-Grade 3 |
3.139600E-01 |
| Grade 2-vs-Grade 4 |
1.074230E-01 |
| Grade 3-vs-Grade 4 |
4.338400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.757100E-03 |
| Normal-vs-ccB subtype |
3.045000E-03 |
| ccA subtype-vs-ccB subtype |
8.956000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.898640E-03 |
| Normal-vs-N1 |
8.467200E-01 |
| N0-vs-N1 |
4.704000E-02 |
|
|
